Scalp Cooling Therapy for Chemotherapy-Induced Hair Loss in Asian Patients with Breast or Gynecological Cancers – A Tertiary Institution Experience

March 2024 in “ Research Square (Research Square) ”

Victor Lee, Jerold Loh, Hui Fu, Raghav Sundar, Belinda Tan, Lee Moy Chong, Hui Ying Lin, Lay Ching Ong, Nisha Visvanadan, Samuel Guan Wei Ow, Andrea Li‐Ann Wong, Gloria Chan, Siew Eng Lim, Yi Wan Lim, David S.P. Tan, Yvonne Ang, Joan Choo, Matilda Lee, Natalie Ngoi, Soo Chin Lee, Richard G. Paxman, Anna Parker, Yee Mei Lee, Joline Si Jing Lim

scalp cooling therapy chemotherapy-induced hair loss Paxman system paclitaxel anthracycline cyclophosphamide hair preservation hair regrowth SCT

TLDR Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Scalp cooling therapy (SCT) was evaluated in 83 Asian women with breast or gynecological cancers undergoing chemotherapy at a tertiary institution. The study, conducted over 18 months, involved 510 SCT cycles using the Paxman system. Results showed that 94% of patients found SCT comfortable. Hair preservation success was highest in patients receiving weekly paclitaxel (76.7%) and lower in those on a 3-weekly paclitaxel regimen (50%) or anthracycline and cyclophosphamide (5.3%). Overall, SCT was well tolerated and significantly improved hair preservation or regrowth compared to historical controls.

View this study on researchsquare.com →

Scalp Cooling Therapy for Chemotherapy-Induced Hair Loss in Asian Patients with Breast or Gynecological Cancers – A Tertiary Institution Experience

Related

research Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil

research Safety and Efficacy of Trimax-360 Serum in Healthy Adult Subjects with Mild to Moderate Alopecia of the Scalp

research Significant Relationship Between Temporal Hair Loss and Other Scalp Areas in Female Pattern Hair Loss

research The Changing Patterns of Hair Density and Thickness in South Korean Women with Hair Loss: Clinical Office-Based Phototrichogram Analysis